Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has ...

Dr. Meghraj Ingle reminds nonalcoholic fatty liver disease (NAFLD), which got no noticeable symptoms in its early stages, can ...

The global human liver model market, valued at $1.34 billion in 2024, is projected to grow at a CAGR of 14.04% through 2030, ...

16-year-old Indian youth, Aditya Kumar Jha from VIBGYOR High School, Mumbai, has established himself as a force to be ...

At 2 years, participants in the compensated MASH cirrhosis treatment arm of the MAESTRO-NAFLD-1 trial experienced a ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...

Fatty liver is a health crisis that occurs when more than 5% of fat builds up in the liver due to various behavioural and ...

Interventional Oncology Market Interventional Oncology Market Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Interventional ...

Discover the 7 major risk factors for liver cancer, from viral hepatitis to genetics. Learn how lifestyle changes and early ...

Madrigal Pharmaceuticals (MDGL) reported positive two-year results from the open-label compensated MASH cirrhosis arm of the Phase 3 ...

Fatty liver disease is not just linked to alcohol and taking proactive steps, you can effectively manage and potentially ...